Pharmacovigilance:
The changing role of drug safety in today’s development process

 

The effect of globalization on pharmacovigilance

 

Improving the detection and reporting of safety problems

 

Preventing crises in drug safety–a shared responsibility

 

The benefits of drug safety partnerships

 

Biostatistics:
A Critical Component of Pharmacovigilance

 

Data Safety Monitoring Boards: Another dimension of protection

 

ICON Profile

With Suzanne Gagnon Senior Vice President and Global Head of Medical Affairs and Drug Safety

 

Did you know?

Fast facts about ICON’s drug safety and pharmacovigilance expertise

 

ICON Events

View our upcoming calendar of events

 

About ICON
Company overview and contact details

About ICON

 

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has 50 offices in 30 countries.

 

Further information is available on www.iconclinical.com

 

Contact Details

 

Erica Hill

Tel: +1 215-616-3000

Email: hillE@iconus.com

 

ICON Insight

ICON Clinical Research

212 Church Road

North Wales

PA 19454

 

Phone: US +1 215 626 3000 / Europe +44 23 8068 8500

Email: insight@iconus.com

Website: www.iconclinical.com